Carotid Artery Stenosis Clinical Trial
Official title:
Research on Changes of Cerebral Vascular Morphology and Cognitive Function in Patients With Carotid Artery Stenosis Before and After Surgery
The purpose of this study is to explore the relationship between the recovery of cerebrovascular morphology and cognitive function before and after surgical treatment in patients with carotid artery stenosis and their preoperative cardiac health status. And combined with preoperative cognitive status, serum markers, and cardiovascular health evaluation indicators, evaluate and predict the possibility of postoperative neurodegenerative diseases and the level of cerebrovascular health in patients.
Status | Not yet recruiting |
Enrollment | 100 |
Est. completion date | December 31, 2025 |
Est. primary completion date | December 31, 2025 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 50 Years to 80 Years |
Eligibility | Inclusion Criteria: - Aged over 50 years old; - Conscious and capable of completing neuropsychological scales - Clinical detection of carotid artery stenosis requires surgical treatment; - Compliant with carotid artery stenting or carotid endarterectomy surgical standards - Individuals with normal cognition and mild cognitive impairment Exclusion Criteria: - Degree of vascular blockage in other intracranial segments = 50% - Have a history of mental illness, nervous system disease (such as stroke) or brain injury with loss of consciousness for more than five minutes; - Neurological and psychiatric disorders unrelated to AD (schizophrenia, depression, etc.), post-traumatic stress disorder, obsessive-compulsive disorder, multiple sclerosis, amyotrophic lateral sclerosis) - Have a history of alcohol or drug abuse - There are contraindications for magnetic resonance imaging examination - Those with significant organ dysfunction such as lung, liver, and kidney; - Patients with intracranial tumors, infectious diseases, and blood system diseases; - Participating in other clinical studies at the same time |
Country | Name | City | State |
---|---|---|---|
China | The 2rd School of Medicine,WMU/The 2rd Affiliated Hospital and Yuying Children's Hospiyal of WMU | Wenzhou | Zhejiang |
Lead Sponsor | Collaborator |
---|---|
Nanjing University of Traditional Chinese Medicine | Health Science Center of Xi'an Jiaotong University, The 2rd School of Medicine,WMU/The 2rd Affiliated Hospital and Yuying Children's Hospiyal of WMU |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change of brain volume before and after treatment | The change of brain volume (mm3) are evaluated by structural 3DT1 weighted MRI. Freesurfer software is used to get the measured value of the volume. | before operation; 3-10 Days after operation; 1 month; 6-12months] | |
Primary | Change of cerebrovascular morphology before and after treatment | The change of Cerebral vessel density, caliber and tortuosity, brain white matter hyperintensity lesion count | before operation; 3-10 Days after operation; 1 month; 6-12months | |
Primary | Change of brain function connectivity before and after operation | The change of brain functional connectivity intensity are evaluated by rest stage functional MRI. DPABI software based on MATLAB is used to get the measured the matrix value of functional connectivity. | before operation; 3-10 Days after operation; 1 month; 6-12months | |
Secondary | Change of serum marker concentration before and after operation | The change of serum marker concentration is evaluated by inflammatory cytokine. | before operation; 3-10 Days after operation; 1 month; 6-12months | |
Secondary | Change of plasma marker concentration before and after operation | The change of plasma marker concentration is evaluated by neurofilament light chain(NFL) protein extracted from plasma. | before operation; 3-10 Days after operation; 1 month; 6-12months | |
Secondary | Brain evaluate basic cognition before operation | Basic cognition is evaluated by Mini-mental State Examination (MMSE) and Clinical Dementia Rating (CDR) . For MMSE , The minimum value is 0 , and the maximum value is 30. The higher scores mean a better outcome. For CDR , the results are represented by scores of 0,0.5,1,2,3, and the degree of cognitive impairment is classified as normal, suspicious, mild, moderate, and severe | before operation | |
Secondary | Change of executive functions before and after operation evaluated by Trail-Making Test Part A | The change of executive functions are first evaluated by Trail-Making Test Part A test. The minimum value is 0 , and the maximum value is 30. This test has no clear maximum and minimum values. If the test completion time exceeds 79 seconds, it means the outcome is abnormal. The higher scores mean a worse outcome. | before operation; 3-10 Days after operation; 1 month; 6-12months | |
Secondary | Change of executive functions before and after operation evaluated by Digit Symbol Coding score | The change of executive functions are second evaluated by Digit Symbol Coding score. The minimum value is 0 , and the maximum value is not clear. The normal range of results is 56.53 ± 20.17. The higher scores mean a better outcome. | before operation; 3-10 Days after operation; 1 month; 6-12months | |
Secondary | Change of working memory before and after operation evaluated by Forward Digit Span | The change of working memory is first evaluated by Forward Digit Span. The minimum value is 0 , and the maximum value is not clear. The normal range of results is 7.75±1.47. The higher scores mean a better outcome. | before operation; 3-10 Days after operation; 1 month; 6-12months | |
Secondary | Change of working memory before and after operation evaluated by Backward Digit Span | The change of working memory is second evaluated by Backward Digit Span. The minimum value is 0 , and the maximum value is not clear. The normal range of results is 5.36±1.91. The higher scores mean a better outcome. | before operation; 3-10 Days after operation; 1 month; 6-12months | |
Secondary | Change of language function before and after operation evaluated by Language Fluency test | The change of language function is evaluated by Language Fluency test. The minimum value is 0 , and the maximum value is not clear. The normal range of results is 19.43±4.81. The higher scores mean a better outcome. | before operation; 3-10 Days after operation; 1 month; 6-12months | |
Secondary | Change of executive functions before and after operation evaluated by Clock Drawing Test | The change of executive functions is evaluated by Backward Digit Span. The minimum value is 0 , the maximum value is 4. | before operation; 3-10 Days after operation; 1 month; 6-12months | |
Secondary | Change of executive functions before and after operation evaluated by Trail-Making Test Part B | The change of executive functions are first evaluated by Trail-Making Test Part B test. The minimum value is 0 , and the maximum value is 30. This test has no clear maximum and minimum values. If the test completion time exceeds 79 seconds, it means the outcome is abnormal. The higher scores mean a worse outcome.It is a supplement to Trail-Making Test Part A, which is optional for patients who are not familiar with the English alphabetical order | before operation; 3-10 Days after operation; 1 month; 6-12months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT03931161 -
Effect of Evolocumab on Carotid Plaque Composition in Asymptomatic Carotid Artery Stenosis (EVOCAR-1)
|
Phase 4 | |
Recruiting |
NCT03353103 -
Imaging of Unstable Carotid Plaque in Patient Referred to Endarterectomy
|
Phase 2 | |
Completed |
NCT03996148 -
Time to Post-Anesthesia Neurological Evaluation With Three Different Anesthetic Techniques
|
Phase 4 | |
Recruiting |
NCT05968053 -
Detection of Microplastics and Nanoplastics in Neurosurgery Patients (DT-MiNi)
|
||
Completed |
NCT00318851 -
Carotid Artery Stenting With Protection Registry
|
Phase 3 | |
Completed |
NCT00597974 -
Neurological Outcome With Carotid Artery Stenting
|
N/A | |
Active, not recruiting |
NCT05293067 -
Troponin In Carotid Revascularization
|
||
Completed |
NCT03133429 -
Clinical Study to Evaluate the Safety and Effectiveness of MER® Stents in Carotid Revascularisation.
|
N/A | |
Recruiting |
NCT01440036 -
The Correlation Between the Enzyme Paraoxigenase 1 (PON1) to Carotid Artery Atheromatous Plaque
|
N/A | |
Completed |
NCT00417963 -
ViVEXX Carotid Revascularization Trial (VIVA)
|
Phase 3 | |
Completed |
NCT00177346 -
A Randomized Trial of Carotid Artery Stenting With and Without Cerebral Protection
|
N/A | |
Recruiting |
NCT05574972 -
Timing Carotid Stent Clinical Study for the Treatment of Carotid Artery Stenosis(Timing Trial)
|
N/A | |
Recruiting |
NCT02476396 -
Structural Stability of Carotid Plaque and Symptomatology
|
||
Completed |
NCT05451485 -
VFI in Healthy Vessels
|
||
Recruiting |
NCT06033963 -
Safety and Efficacy of Remote Ischemic Conditioning in Patients With Carotid Artery Stenosis Receiving Carotid EndArterectomy
|
N/A | |
Not yet recruiting |
NCT02224209 -
Comparison of Staged Angioplasty and Routine Single-stage Stenting (CAS) in the Treatment of Carotid Artery Stenosis
|
Phase 4 | |
Completed |
NCT02006095 -
Neuroimaging Correlates of Memory Decline Following Carotid Interventions
|
||
Terminated |
NCT01236508 -
Relation of Carotid Artery Plaque Inflammation, Covert Stroke and White Matter Disease
|
Phase 4 | |
Recruiting |
NCT05126238 -
A Lithium-Based Medication to Improve Neurological Outcomes After Surgical Carotid Reconstruction
|
Phase 3 | |
Recruiting |
NCT06170580 -
Improved Image Quality for Assessment of Carotid Artery Stenosis by Ultrafast Ultrasound FLOW Imaging
|